Top Markets
#1 Pleasing Gold Pleasing Gold +632.35%
#2 Islamic Coin Islamic Coin +154.16%
#3 PulseChain PulseChain +52.83%
#4 BOOK OF MEME BOOK OF MEME +46.61%
#5 DogBull DogBull +36.93%
#6 Neiro Neiro +27.33%
#7 Nockchain Nockchain +22.65%
#8 ORDI ORDI +19.28%
#9 rsERG rsERG +16.70%
#10 Monad Monad +16.28%
Coin of the day
Pleasing Gold Pleasing Gold
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Cyfuse Biomedical K.K. Cyfuse Biomedical K.K.

Cyfuse Biomedical K.K.

4892
Rangering i aksjer #26819
Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K.... Established in 2010 and headquartered in Tokyo, Japan, Cyfuse Biomedical K.K. focuses on the creation, production, and distribution of regenerative medicine solutions. The company is actively involved in developing cell-based products for therapeutic regeneration, and it also undertakes contract work for cellular product research and development. Furthermore, Cyfuse Biomedical offers advanced Bio 3D Printers, which are instrumental in regenerating a variety of tissues and organs, including cartilage, bones, blood vessels, and nerves. Their specialized equipment includes 'regenova,' a bio 3D printer enabling three-dimensional cell stacking, and 'S-PIKE,' designed for forming complex 3D structures from cells.
Aksjekurs
$3.72
Markedsverdi
$37.53M
Endring (1 dag)
4.78%
Endring (1 år)
-18.34%
Land
JP
Handel Cyfuse Biomedical K.K. (4892)

Kategori

Healthcare
Inntekter for Cyfuse Biomedical K.K. (4892)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til Cyfuse Biomedical K.K. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for Cyfuse Biomedical K.K. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH